Opinion: Yes, we need a vaccine to control Covid-19. But we need new treatments, too
Hopes for a relatively quick return to normalcy are riding high on promising news about…
Author: STAT
Opinion: Ventilation should be part of the conversation on school reopening. Why isn’t it?
Like every other parent with a school-age child, I want schools to reopen in the…
Telemedicine is booming — but many people still face huge barriers to virtual care
As Covid-19 drives many patients away from in-person care and toward virtual visits, experts warn…
STAT Plus: Haven was supposed to reimagine health care. An exodus of talent has gutted it
Haven, the audacious health venture founded by three of America’s most storied companies, was once…
STAT Plus: Scientists are testing pricey rare-disease drugs as Covid-19 treatments. What if one works?
Some of the existing drugs scientists are testing as Covid-19 treatments have a special status…
Novavax’s Covid-19 vaccine shows promising immune response, early data show
A potential Covid-19 vaccine from the biotech company Novavax showed a promising immune response in…
STAT Plus: State attorneys general urge HHS to sidestep Gilead patents to increase remdesivir access
A bipartisan group of state attorneys general is urging the federal government to sidestep the…
STAT Plus: The FDA is finalizing its long-awaited rules for CBD
A version of this story first ran in D.C. Diagnosis, STAT’s weekly newsletter about the…
STAT Plus: BARDA faces pressure to force Moderna to disclose cost details from its Covid-19 contract
Amid concerns over U.S. government Covid-19 contracts and transparency, Moderna (MRNA) has failed to comply…
New cancer diagnoses fell sharply as the coronavirus pandemic first hit
By almost every measure, far fewer cancers are being diagnosed during the coronavirus pandemic, whether…
STAT Plus: Pharmalittle: Regeneron Covid-19 antibody treatment works in animals; Warren asks SEC to probe Kodak trading
Top of the morning to you, and a fine one it is. Despite a looming…
Opinion: The DRC needs an Ebola survivor program to truly quell its outbreak
If the Democratic Republic of the Congo truly wants to break free of Ebola, it…
Opinion: Children will pay long-term stress-related costs of Covid-19 unless we follow the science
The world is learning more about the uncommon but puzzling ways Covid-19 can show up…
Following court ruling, NIH warns drug and device companies to post missing trial data
WASHINGTON — Hundreds of drug companies, medical device manufacturers, and universities owe the public a…
Covid-19 apps and wearables are everywhere. Can they actually benefit patients?
With Covid-19 cases again climbing, health tech companies and researchers are renewing their pitch for…
STAT Plus: Prescription drugs may be more affordable than you think — unless you pay cash
Amid growing complaints that many Americans cannot afford their prescription medicines, most people in the…
STAT Plus: Gilead faces renewed pressure to pursue remdesivir-like compound to fight Covid-19
In an unusual move, a pair of academics is escalating an effort to convince Gilead…
Nearly half of low-income communities have no ICU beds in their area
As Covid-19 continues to strain the country’s hospital system, new research exposes a striking gap…
STAT Plus: Justice Department probes Sanofi and GlaxoSmithKline over possible carcinogen in Zantac pills
The Department of Justice has started investigating whether drug makers failed to disclose information about…
STAT Plus: Pharmalittle: Lilly starts late-stage trial of Covid-19 antibody; concern grows over political intervention on Covid-19 vaccine
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Music in drug ads makes it easier for the public to tune out side effects, advocates argue
This will not be music to the ears of the pharmaceutical industry. A pair of…
Opinion: Black lives depend on the U.S. dietary guidelines. Don’t water them down
Most Americans know about the Dietary Guidelines for Americans primarily through their colorful representations: the…
Opinion: Measuring excess mortality gives a clearer picture of the pandemic’s true burden
How best to represent the true toll of the Covid-19 pandemic on human lives is…
Getting into U.S. medical schools wasn’t easy for them. Now international students are smoothing the path for others
Long before Azan Virji entered medical school, a college counselor back home in Tanzania tried…
This tiny Texas company is running most of the drive-thru Covid-19 testing in the U.S.
On March 13, President Trump stood next to the CEOs of LabCorp, Quest Diagnostics, Walgreens,…
STAT Plus: In a blow to Catalyst, judge recommends tossing its lawsuit against FDA
A federal court judge recommended tossing out a lawsuit filed by Catalyst Pharmaceuticals (CPRX) that…
Ginkgo Bioworks, Mammoth Biosciences among winners of NIH’s ‘Shark Tank’ for Covid-19 tests
The National Institutes of Health selected Ginkgo Bioworks, Mammoth Biosciences, Quidel, and four other companies…
STAT Plus: Pharmalittle: U.S. hands Glaxo and Sanofi $2.1 billion for a Covid-19 vaccine; Moderna director resigns over conflict concerns
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: CytoDyn CEO claims Covid-19 drug success while describing data suggesting study failure
CytoDyn CEO Nader Pourhassan used a conference call on Thursday evening to claim success with the…
Sanofi and GSK land $2.1 billion deal with U.S. for Covid-19 vaccine development and 100 million doses
The U.S. government’s Operation Warp Speed effort will provide up to $2.1 billion to Sanofi…
.jpg)
Opinion: A Covid-19 vaccine, amazingly, is close. Why am I so worried?
A mere six months after identifying the SARS-CoV-2 virus as the cause of Covid-19, scientists…
Opinion: The curious link between kids’ birthdays and their getting the flu vaccine
Getting the influenza vaccine will be even more important for adults and children this fall…
STAT Plus: The drug industry’s new tactic in Washington: calling Trump’s bluff
WASHINGTON — The pharmaceutical industry has sparred with President Trump for four years over drug…
Medical nonprofits forced to scale back as the pandemic upends their fundraising
Medical charities have long relied on black-tie galas, golf tournaments, and bike-a-thons to fund their…
STAT Plus: Prominent hospital president resigns from Moderna board after conflict of interest questions raised
Dr. Elizabeth Nabel, president of Brigham and Women’s Hospital, said Thursday she was resigning from…
Listen: Inside the NBA bubble, a DIY coronavirus vaccine, and the real VC numbers
How much should a Covid-19 vaccine cost? What can basketball teach us about pandemic safety?…
STAT Plus: Pharmalittle: Drug makers build Covid-19 vaccine supply chains; VCs are still spending on biotechs
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
STAT Plus: Coles-led Cerevel Therapeutics to raise $445 million to develop brain drugs with fewer side effects
Cerevel Therapeutics, a Boston neuroscience company spun out from Pfizer in 2018 and led by…
STAT Plus: Drug maker settles charges of offering ‘bogus’ research grants to boost use of its medicine
In the latest imbroglio involving drug makers and kickbacks, Pacira Biosciences (PCRX) has agreed to…
Opinion: The nursing science behind nurses as coronavirus hospital heroes
The coronavirus pandemic has given nurses a rare moment in the media spotlight. They are…
Opinion: Sexist and incomplete data hold back the world’s Covid-19 response
How many women have died of Covid-19? How many women have lost their jobs in…
STAT Plus: Venture capitalists are still showering biotechs with cash, even as the coronavirus upends markets
Venture capitalists are still spending big on biotech companies, even four months after the coronavirus…
‘A huge experiment’: How the world made so much progress on a Covid-19 vaccine so fast
Never before have prospective vaccines for a pathogen entered final-stage clinical trials as rapidly as…
Opinion: A NASA mindset can help end the pandemic
Eight months into the global coronavirus pandemic, the life sciences industry is ramping up drug…
STAT Plus: Seeking to battle high drug prices and the opioid crisis, two states ponder banning gifts to doctors
Over the past month, lawmakers in two states have introduced bills that would ban drug…
School closures in spring linked to drastic decrease in Covid-19 cases and deaths
When state officials were deciding whether to shutter their schools back in March, the evidence…
Webinar: Inside the virtual care boom: What happens when the point of care becomes anywhere?
Virtual care and digital health tools are soaring in popularity amid the Covid-19 pandemic. A…
STAT Plus: MacKenzie Scott, with a massive Amazon fortune, emerges as a public health philanthropist
You may not know the name MacKenzie Scott – the author just started going by…
STAT Plus: Pharmalittle: Global supply chain not ready for Covid-19 vaccines; Moderna may price its vaccine at up to $60
Good morning, everyone, and welcome to the middle of the week. You made it this…
STAT Plus: Cancer drug is the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration
The pharmaceutical giant GlaxoSmithKline is starting human trials of the first medicine, a cancer drug,…